Antiplatelet Agents

Thomas G. DeLoughery

doi:10.1007/978-3-030-19330-0_26

Antiplatelet Agents

Thomas G. DeLoughery

Knight Cancer Institute

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

This chapter discusses agents that inhibit platelet function - aspirin, P2Y12 receptor blockers, Gp IIb/IIIa inhibitors, and other agents. The mechanism of actions, indications, and toxicities are listed for each agent.

Original language	English (US)
Title of host publication	Hemostasis and Thrombosis
Subtitle of host publication	Fourth Edition
Publisher	Springer International Publishing
Pages	169-174
Number of pages	6
ISBN (Electronic)	9783030193300
ISBN (Print)	9783030193294
DOIs	https://doi.org/10.1007/978-3-030-19330-0_26
State	Published - Jan 1 2019

Keywords

Abciximab
Aspirin
Dipyridamole
Gp IIb/IIIa inhibitors
Vorapaxar

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-3-030-19330-0_26

Cite this

@inbook{d484ab5d762f482a8815a771ae69b322,

title = "Antiplatelet Agents",

abstract = "This chapter discusses agents that inhibit platelet function - aspirin, P2Y12 receptor blockers, Gp IIb/IIIa inhibitors, and other agents. The mechanism of actions, indications, and toxicities are listed for each agent.",

keywords = "Abciximab, Aspirin, Dipyridamole, Gp IIb/IIIa inhibitors, Vorapaxar",

author = "DeLoughery, {Thomas G.}",

note = "Publisher Copyright: {\textcopyright} Springer Nature Switzerland AG 2019.",

year = "2019",

month = jan,

day = "1",

doi = "10.1007/978-3-030-19330-0_26",

language = "English (US)",

isbn = "9783030193294",

pages = "169--174",

booktitle = "Hemostasis and Thrombosis",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Antiplatelet Agents

AU - DeLoughery, Thomas G.

N1 - Publisher Copyright: © Springer Nature Switzerland AG 2019.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - This chapter discusses agents that inhibit platelet function - aspirin, P2Y12 receptor blockers, Gp IIb/IIIa inhibitors, and other agents. The mechanism of actions, indications, and toxicities are listed for each agent.

AB - This chapter discusses agents that inhibit platelet function - aspirin, P2Y12 receptor blockers, Gp IIb/IIIa inhibitors, and other agents. The mechanism of actions, indications, and toxicities are listed for each agent.

KW - Abciximab

KW - Aspirin

KW - Dipyridamole

KW - Gp IIb/IIIa inhibitors

KW - Vorapaxar

UR - http://www.scopus.com/inward/record.url?scp=85148808079&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85148808079&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-19330-0_26

DO - 10.1007/978-3-030-19330-0_26

M3 - Chapter

AN - SCOPUS:85148808079

SN - 9783030193294

SP - 169

EP - 174

BT - Hemostasis and Thrombosis

PB - Springer International Publishing

ER -

Antiplatelet Agents

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this